BERKELEY HEIGHTS, N.J., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders (the "Company"), announced that Spiro Rombotis, President and CEO, will present an overview of the Company at the Rodman & Renshaw 12th Annual Healthcare Conference at the Palace Hotel in New York. The presentation will take place on Monday, September 13 at 3:15 p.m. Eastern.
